LMDXW | LumiraDx Limited Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0040 - 0.0058
52 Week Range	0.0040 - 0.0058
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	325,935
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	1,302,798
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2021-09-29

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	-2.93
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,210
Country	UK
Website	LMDXW

LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.

LMDXW's peers: PROCW

*Chart delayed

Analyzing fundamentals for LMDXW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see LMDXW Fundamentals page.

Watching at LMDXW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on LMDXW Technicals page.